Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15276324rdf:typepubmed:Citationlld:pubmed
pubmed-article:15276324lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:15276324lifeskim:mentionsumls-concept:C0002062lld:lifeskim
pubmed-article:15276324lifeskim:mentionsumls-concept:C0026255lld:lifeskim
pubmed-article:15276324lifeskim:mentionsumls-concept:C0007586lld:lifeskim
pubmed-article:15276324lifeskim:mentionsumls-concept:C0041348lld:lifeskim
pubmed-article:15276324lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:15276324lifeskim:mentionsumls-concept:C0521033lld:lifeskim
pubmed-article:15276324lifeskim:mentionsumls-concept:C0314672lld:lifeskim
pubmed-article:15276324lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:15276324lifeskim:mentionsumls-concept:C0237477lld:lifeskim
pubmed-article:15276324lifeskim:mentionsumls-concept:C1506550lld:lifeskim
pubmed-article:15276324pubmed:issue1lld:pubmed
pubmed-article:15276324pubmed:dateCreated2004-7-27lld:pubmed
pubmed-article:15276324pubmed:abstractTextOxaline and neoxaline, fungal alkaloids, were found to inhibit cell proliferation and to induce cell cycle arrest at the G(2)/M phase in Jurkat cells. CBP501 (a peptide corresponding to amino acids 211-221 of Cdc25C phosphatase), which inhibits the G(2) checkpoint, did not affect the G(2)/M arrest caused by oxaline, suggesting that oxaline causes M phase arrest but not G(2) phase arrest. The Cdc2 phosphorylation level of oxaline-treated cell lysate was lower than that of the control cells, indicating that oxaline arrests the M phase. Oxaline disrupted cytoplasmic microtubule assembly in 3T3 cells. Furthermore, oxaline inhibited polymerization of microtubule protein and purified tubulin dose-dependently in vitro. In a binding competition assay, oxaline inhibited the binding of [(3)H]colchicine to tubulin, but not that of [(3)H]vinblastine. These results indicate that oxaline inhibits tubulin polymerization, resulting in cell cycle arrest at the M phase.lld:pubmed
pubmed-article:15276324pubmed:languageenglld:pubmed
pubmed-article:15276324pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15276324pubmed:citationSubsetIMlld:pubmed
pubmed-article:15276324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15276324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15276324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15276324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15276324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15276324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15276324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15276324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15276324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15276324pubmed:statusMEDLINElld:pubmed
pubmed-article:15276324pubmed:monthJullld:pubmed
pubmed-article:15276324pubmed:issn0006-3002lld:pubmed
pubmed-article:15276324pubmed:authorpubmed-author:OmuraSatoshiSlld:pubmed
pubmed-article:15276324pubmed:authorpubmed-author:KoizumiYukioYlld:pubmed
pubmed-article:15276324pubmed:authorpubmed-author:AraiMasayoshi...lld:pubmed
pubmed-article:15276324pubmed:authorpubmed-author:TomodaHiroshi...lld:pubmed
pubmed-article:15276324pubmed:issnTypePrintlld:pubmed
pubmed-article:15276324pubmed:day23lld:pubmed
pubmed-article:15276324pubmed:volume1693lld:pubmed
pubmed-article:15276324pubmed:ownerNLMlld:pubmed
pubmed-article:15276324pubmed:authorsCompleteYlld:pubmed
pubmed-article:15276324pubmed:pagination47-55lld:pubmed
pubmed-article:15276324pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15276324pubmed:meshHeadingpubmed-meshheading:15276324...lld:pubmed
pubmed-article:15276324pubmed:meshHeadingpubmed-meshheading:15276324...lld:pubmed
pubmed-article:15276324pubmed:meshHeadingpubmed-meshheading:15276324...lld:pubmed
pubmed-article:15276324pubmed:meshHeadingpubmed-meshheading:15276324...lld:pubmed
pubmed-article:15276324pubmed:meshHeadingpubmed-meshheading:15276324...lld:pubmed
pubmed-article:15276324pubmed:meshHeadingpubmed-meshheading:15276324...lld:pubmed
pubmed-article:15276324pubmed:meshHeadingpubmed-meshheading:15276324...lld:pubmed
pubmed-article:15276324pubmed:meshHeadingpubmed-meshheading:15276324...lld:pubmed
pubmed-article:15276324pubmed:meshHeadingpubmed-meshheading:15276324...lld:pubmed
pubmed-article:15276324pubmed:meshHeadingpubmed-meshheading:15276324...lld:pubmed
pubmed-article:15276324pubmed:meshHeadingpubmed-meshheading:15276324...lld:pubmed
pubmed-article:15276324pubmed:meshHeadingpubmed-meshheading:15276324...lld:pubmed
pubmed-article:15276324pubmed:meshHeadingpubmed-meshheading:15276324...lld:pubmed
pubmed-article:15276324pubmed:meshHeadingpubmed-meshheading:15276324...lld:pubmed
pubmed-article:15276324pubmed:meshHeadingpubmed-meshheading:15276324...lld:pubmed
pubmed-article:15276324pubmed:year2004lld:pubmed
pubmed-article:15276324pubmed:articleTitleOxaline, a fungal alkaloid, arrests the cell cycle in M phase by inhibition of tubulin polymerization.lld:pubmed
pubmed-article:15276324pubmed:affiliationKitasato Institute for Life Sciences and Graduate School of Infection Control Sciences, Kitasato University and The Kitasato Institute, 5-9-1 Shirokane, Minato, Tokyo 108-8641, Japan.lld:pubmed
pubmed-article:15276324pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15276324pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15276324lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15276324lld:pubmed